Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Z-Cube And Yissum Research Development Company Ltd. Sign A Licensing Agreement
Z-Cube Srl, the corporate venture arm of Zambon Company SpA, and Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, announced today that they have entered into a license agreement for Z-Cube to develop and commercialize an innovative nanotechnology drug delivery system for the treatment of pain. The technology was invented by Professor Elka Touitou from the Department of Pharmaceutics, Faculty of Medicine, at the Hebrew University of Jerusalem.
generic viagra online
MAP Pharmaceuticals Phase 3 Trial Of Levadex™ Migraine Product Candidate Meets All Four Primary Endpoints
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced that the efficacy portion of its first Phase 3 clinical trial evaluating its novel LEVADEX™ orally inhaled migraine therapy met all four primary endpoints. Additional endpoints showed that LEVADEX provided rapid and sustained pain relief for up to 48 hours after dosing.
News of the day
Light Sciences Oncology Announces Results Of Study On Immunotherapeutic Mechanism Of Aptocine(TM), A Novel Light-Activated Drug Therapy For Cancer
Light Sciences Oncology, Inc. (LSO) announced that a new preclinical study has yielded evidence that the company"s novel light-activated drug Aptocine(TM) (formerly Litx(TM)) may enhance anti-tumor immunity and prevent metastases. Results of the study will be presented in a poster session at the annual American Society of Clinical Oncology (ASCO) meeting in Orlando, Florida, on May 30, 8:00 AM - 12:00 PM. The study was conducted by Dr. Sandra Gollnick at the Roswell Park Cancer Institute in Buffalo, New York.
Cardiovascular

An End To Inequalities Will Further Boost Heart Surgery Survival Rates, Says British Heart Foundation

In response to the publication of Demonstrating Quality: The Sixth National Adult Cardiac Surgical Database Report (1) which examined outcomes for adult cardiac patients British Heart Foundation (BHF) Associate Medical Director Dr Mike Knapton said: "This report shows that patients have increasingly better chances of survival following cardiac surgery even though the people undergoing these operations are more likely to be older and sicker. "However, while demonstrating a high quality of care and progress, it also highlights variations in access to aortic valve surgeries in England. Local healthcare providers need to urgently investigate why this is. "If we are to tackle these inequalities and meet the needs of an increasingly elderly and obese population we need a robust strategy to meet the future demand for cardiac surgery. The BHF is part of the Cardio and Vascular Coalition which is calling for a planned approach to cardiovascular provision in the coming decade." (1) Prepared in response to: Demonstrating Quality: The Sixth National Adult Cardiac Surgical Database Report, published by Society for Cardiothoracic Surgery of GB and Ireland and Dendrite Clinical Systems Ltd, 30/07/2009 The British Heart Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009